coronavirus
envelop
rna
virus
wide
detect
mammal
bird
commonli
denot
etiolog
upper
respiratori
tract
infect
human
two
potenti
danger
zoonot
coronavirus
emerg
past
two
decad
sever
acut
respiratori
syndrom
coronaviru
sarscov
origin
china
respons
first
outbreak
extend
second
outbreak
occur
middl
east
caus
middl
east
respiratori
syndrom
coronaviru
merscov
new
strain
coronaviru
design
novel
coronaviru
emerg
third
outbreak
wuhan
china
end
symptom
pneumonia
unknown
etiolog
report
sever
patient
infect
epidemiolog
link
huanan
seafood
market
wuhan
similar
sarscov
merscov
bat
denot
like
primari
reservoir
base
similar
bat
coronavirus
intermediari
reservoir
yet
denot
pertin
critic
factor
emerg
viru
pandem
potenti
effici
humantohuman
transmiss
requir
largescal
spread
new
viru
proport
patient
mild
symptom
ill
anoth
import
factor
determin
abil
identifi
infect
individu
prevent
spread
viru
identif
transmiss
chain
subsequ
contact
trace
complic
sever
infect
individu
remain
asymptomat
mildli
symptomat
key
factor
effici
humantohuman
transmiss
abil
viru
attach
human
cell
coronavirus
use
spike
protein
attach
host
cell
appar
use
human
angiotensinconvert
enzym
receptor
sarscov
wherea
merscov
use
dipeptidyl
peptidas
also
known
effici
humantohuman
transmiss
involv
multipl
rout
transmiss
includ
droplet
transfer
direct
contact
indirect
contact
limit
humantohuman
transmiss
may
requir
high
infect
dose
significantli
close
contact
infect
person
prerequisit
tabl
three
zoonot
coronaviru
outbreak
recent
decad
associ
pneumonia
patient
sever
ill
avail
data
suggest
may
less
pathogen
merscov
sarscov
tabl
howev
sever
diseas
necessarili
link
transmiss
effici
pandem
potenti
rapidli
increas
number
case
suggest
viru
may
transmit
effect
among
human
mild
ill
may
quit
common
infect
individu
two
featur
confer
high
pandem
potenti
tabl
next
import
factor
consid
outbreak
abil
contain
spread
new
viru
lag
three
month
commenc
sar
epidem
initi
investig
healthcar
offici
china
consequ
infect
spread
approxim
peopl
countri
result
death
sinc
mild
ill
uncommon
sar
infect
infect
individu
easili
identifi
sar
could
contain
effect
erad
without
vaccin
effect
antivir
therapi
current
limit
number
studi
china
investig
efficaci
potenti
lopinavirritonavir
kaletra
combin
proteas
inhibitor
use
treat
prevent
hivaid
treatment
infect
agent
includ
nucleosid
analogu
neuraminidas
inhibitor
remdesivir
umifenovir
arbidol
tenofovir
disoproxil
tdf
lamivudin
along
sever
chines
tradit
medicin
report
viabl
option
antivir
treatment
human
pathogen
coronaviru
clinic
efficaci
remdesivir
treatment
first
us
case
pneumonia
caus
recent
report
howev
data
deriv
preliminari
stage
studi
insuffici
support
implement
clinic
use
treatment
infect
sever
lack
inform
initi
stage
outbreak
pose
challeng
complic
contain
infect
specif
limit
area
higher
proport
mild
infect
facilit
rapid
spread
viru
present
effort
contain
may
complet
effect
howev
hope
effort
may
delay
spread
provid
us
suffici
time
develop
effect
vaccin
antivir
agent
viru
author
declar
conflict
interest
